AVAI · Avai Bio, Inc. · Metrics
$0.10
-0.01 (-10.61%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Therefore, there is substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$15.39M
Shares
153.92M
Volume · Oct 21
61.4K
Avg daily vol (3M)
103.4K
AVAI metrics
49 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$0.10
Market cap
$15.39M
Price action
20 metricsPrice change (1W)
-10.7%
Price change (30D)
-25.5%
Price change (3M)
-44.4%
Price change (6M)
-67.8%
Price change (YTD)
-72.9%
Price change (1Y)
-77.2%
Trailing year
Price change (5Y)
-93.0%
52-week high
$0.78
52-week low
$0.10
Change from 52-week high
-86.8%
Change from 52-week low
+1.8%
Annualized volatility
122.0%
Annualized volatility (3M)
122.7%
Beta
0.7
RSI (14D)
36.6
Price vs SMA 50
-16.2%
Price vs SMA 200
-61.3%
Avg volume (3M)
103,401
Relative volume
0.6
Average dollar volume
$13,510
Company
3 metricsSector
Technology
Industry
Software - Application
Shares outstanding
153.92M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-18.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
-14.6%
Operating margin
-126.3%
Trailing 12 months
Net margin
-126.3%
Gross profit (TTM)
−$40,453
Operating profit (TTM)
−$2.79M
Net income (TTM)
−$2.79M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
-213.2%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-352.3%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
−$2.76M
Free cash flow (TTM)
—
Quick ratio
0.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$1.40M
Latest balance sheet
Cash & equivalents
$83,586
Total assets
$791,750
Total debt
$1.48M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$1.18M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
36 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged